Showcases Stock ranks Forex

Merck & Company (MRK)
78.29  -0.4 (-0.51%) 05-14 16:02
Open: 77.71 Pre. Close: 77.46
High: 78.53 Low: 77.3
Volume: 9,254,988 Market Cap: 198,175M
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; Intec Pharma Ltd.; and Transcenta Holding Ltd. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 79.235 - 79.689 79.689 - 80.1
Low: 77.166 - 77.665 77.665 - 78.116
Close: 77.575 - 78.372 78.372 - 79.091
Stock Technical Analysis
Target: Six months: 92.84
One year: 108.44
Support: Support1: 75.39
Support2: 72.85
Resistance: Resistance1: 79.49
Resistance2: 92.84
Pivot: 77.11
Moving Averages: MA(5): 78.12
MA(20): 77.40
MA(100): 77.47
MA(250): 79.33
MACD: MACD(12,26): 0.41
Signal(12,26,9): 0.25
%K %D: %K(14,3): 86.52
%D(3): 81.50
RSI: RSI(14): 56.17
52-Week: High: 87.8
Low: 71.72
Change(%): -1.8
Average Vol(K): 3-Month: 1243428
10-Days: 1101754
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

MRK has closed below upper band by 29.0%. Bollinger Bands are 8.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 14 May 2021
Merck & Co. Inc. stock falls Friday, underperforms market - MarketWatch

Fri, 14 May 2021
Merck Animal Health Bestows $270,000 in Scholarship Support to 54 Veterinary Students Around the World - Hoard's Dairyman

Fri, 14 May 2021
Merck (MRK) is a Top Dividend Stock Right Now: Should You Buy? - Yahoo Finance

Thu, 13 May 2021
Merck, GSK and Pfizer vaccines get a boost as CDC lifts two-week restriction on pandemic shots - FiercePharma

Thu, 13 May 2021
Merck's Keytruda has more data in early triple-negative breast cancer. Will the FDA reverse its prior rejection? - FiercePharma

Thu, 06 May 2021
Fusion Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate Fusion's Targeted Alpha Therapy (TAT) in Combination with Merck's KEYTRUDA® (pembrolizumab) in Patients With Solid Tumors Expressing IGF-1R - PRNewswire

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 2530.00
Shares Float (M) 2500.00
% Held by Insiders 0.09
% Held by Institutions 75.78
Shares Short (K) 21020
Shares Short Prior Month (K) 18140
Stock Financials
EPS 2.770
Book Value (p.s.) 10.010
Profit Margin 14.63
Operating Margin 31.66
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 0.2
Gross Profit (p.s.) 13.664
Sales Per Share 18.980
EBITDA (p.s.) 7.364
Qtrly Earnings Growth -1.20
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
PE Ratio 28.26
PEG Ratio
Price to Book value 7.82
Price to Sales 4.12
Price to Cash Flow
Stock Dividends
Dividend 2.480
Dividend Yield 0.03
Dividend Growth 2.600

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator